Compare

Healthcare Realty/$HR

1D1W1M3M6MYTD1Y5YMAX

About Healthcare Realty

Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.
Ticker
$HR
Primary listing
NYSE
Employees
539

HR Metrics

BasicAdvanced
$6.2B
-
-$0.26
0.82
$0.96
5.30%

What the Analysts think about HR

Analyst ratings (Buy, Hold, Sell) for Healthcare Realty stock.
Analyst projections of the future price of Healthcare Realty stock.

Bulls say / Bears say

Second-quarter same-store cash NOI rose 5.1%, occupancy improved to 92.7% and cash leasing spreads were 4.8%. Healthcare Realty raised its full-year 2026 FFO and NOI growth guidance, extending a run of stronger operating results. (Healthcare Realty)
The company refinanced its $600 million 2026 bond maturity with 3% exchangeable notes and reported about $1.6 billion of liquidity at quarter-end. This reduces near-term refinancing pressure and gives it more room to manage upcoming capital needs. (Healthcare Realty, SEC)
Management said the company’s share of recent joint-venture acquisitions carries an approximately 7.5% cash yield, above its estimated 6% implied property yield. Reinvesting sale proceeds into higher-yielding assets could support growth if those returns are realised. (StockAnalysis)
Net debt to adjusted EBITDA was still 5.6x at the end of the second quarter. That leaves the REIT exposed to higher borrowing costs and limits room to take on more debt-funded growth. (Healthcare Realty)
Healthcare Realty reported a second-quarter GAAP loss of $0.13 per share, and its filing records ongoing property impairments. These charges can weigh on reported results and signal that some assets may not deliver the value previously expected. (Healthcare Realty, SEC)
The $700 million exchangeable notes can convert into shares at an initial price of $23.01. If the share price rises above that level, conversion could dilute existing shareholders, although capped calls are intended to limit some dilution. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.

HR Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

HR Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.